Junshi Biosciences Announces Publication of Results from TORCHLIGHT, a Randomized Phase 3 Trial of Toripalimab for the Treatment of Metastatic or Recurrent Triple-negative Breast Cancer in Nature Medicine
Globe Newswire10-01-2024, 10:15
VCI Global Moves to Acquire Award-Winning Digital Marketing Firm in Singapore 23-01-2025, 21:59